Clinical Trial Update: Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral CDB-4124 to placebo in stage I-II primary breast cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Stage Ia Breast Cancer
• Stage Ib Breast Cancer

Drugs mentioned

• CDB-4124 (CDB-4124)

Snippet

Sponsor: Northwestern University | Conditions: Stage IA Breast Cancer, Stage IB Breast Cancer | Phase 2 | Status: UNKNOWN